Literature DB >> 2255527

The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion.

M J Elman1, A K Bhatt, P M Quinlan, C Enger.   

Abstract

In this cross-sectional study, the authors evaluated 197 patients diagnosed with central retinal vein occlusion (CRVO) at the Wilmer Ophthalmological Institute between 1980 and 1985 to determine the risk of systemic disease and mortality. Complete follow-up information for mortality was obtained in 191 (97%). National Health Interview Survey (NHIS) patients and Wilmer cataract patients formed two comparison groups. The prevalence of hypertension was significantly elevated in the CRVO cases when compared with both comparison groups (P less than 0.03, 0.005). The prevalence of diabetes mellitus was increased in CRVO cases in comparison with the NHIS group (P less than 0.005). The prevalence of cerebrovascular or cardiovascular disease was the same for all three groups, as was overall mortality. Mortality was not increased in CRVO cases as compared with United States mortality rates.

Entities:  

Mesh:

Year:  1990        PMID: 2255527     DOI: 10.1016/s0161-6420(90)32379-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  26 in total

Review 1.  Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease.

Authors:  M Chak; G R Wallace; E M Graham; M R Stanford
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

2.  Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.

Authors:  Ingrid U Scott; Paul C VanVeldhuisen; Neal L Oden; Michael S Ip; Barbara A Blodi; Mary Elizabeth Hartnett; Geoff Cohen
Journal:  Ophthalmology       Date:  2011-02       Impact factor: 12.079

Review 3.  Central retinal vein occlusion: what's the story?

Authors:  T H Williamson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

Review 4.  [Surgical treatments for retinal vein occlusion].

Authors:  N Feltgen; H Agostini; L Hansen
Journal:  Ophthalmologe       Date:  2007-04       Impact factor: 1.059

5.  Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4.

Authors:  Ingrid U Scott; Paul C VanVeldhuisen; Michael S Ip; Barbara A Blodi; Neal L Oden; Jacqueline King; Andrew N Antoszyk; Mark A Peters; Michael Tolentino
Journal:  JAMA Ophthalmol       Date:  2017-06-01       Impact factor: 7.389

6.  Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion.

Authors:  A K Vine
Journal:  Trans Am Ophthalmol Soc       Date:  2000

7.  The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; S E Moss; S M Meuer
Journal:  Trans Am Ophthalmol Soc       Date:  2000

8.  Follow up by colour Doppler imaging of 102 patients with retinal vein occlusion over 1 year.

Authors:  S Arséne; B Giraudeau; M-L Le Lez; P J Pisella; L Pourcelot; F Tranquart
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

9.  Influence of diabetes and diabetes type on anatomic and visual outcomes following central rein vein occlusion.

Authors:  J G Santiago; S Walia; J K Sun; J D Cavallerano; Z A Haddad; L P Aiello; P S Silva
Journal:  Eye (Lond)       Date:  2014-02-14       Impact factor: 3.775

10.  Arterial blood flow characteristics in central retinal vein occlusion and effects of panretinal photocoagulation treatment: an investigation by colour Doppler imaging.

Authors:  A M Avunduk; H Dinç; Z Kapicioğlu; S Uğurlu; V Dayanir; E Korkmaz
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.